153 related articles for article (PubMed ID: 26768307)
1. Enhanced delivery of etoposide across the blood-brain barrier to restrain brain tumor growth using melanotransferrin antibody- and tamoxifen-conjugated solid lipid nanoparticles.
Kuo YC; Wang IH
J Drug Target; 2016 Aug; 24(7):645-54. PubMed ID: 26768307
[TBL] [Abstract][Full Text] [Related]
2. Conjugation of melanotransferrin antibody on solid lipid nanoparticles for mediating brain cancer malignancy.
Kuo YC; Chao IW
Biotechnol Prog; 2016 Mar; 32(2):480-90. PubMed ID: 26701338
[TBL] [Abstract][Full Text] [Related]
3. Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation.
Kuo YC; Cheng SJ
Int J Pharm; 2016 Feb; 499(1-2):10-19. PubMed ID: 26721730
[TBL] [Abstract][Full Text] [Related]
4. Dual targeting of solid lipid nanoparticles grafted with 83-14 MAb and anti-EGF receptor for malignant brain tumor therapy.
Kuo YC; Lee CH
Life Sci; 2016 Feb; 146():222-31. PubMed ID: 26784850
[TBL] [Abstract][Full Text] [Related]
5. Inhibition against growth of glioblastoma multiforme in vitro using etoposide-loaded solid lipid nanoparticles with p-aminophenyl-α-D-manno-pyranoside and folic acid.
Kuo YC; Lee CH
J Pharm Sci; 2015 May; 104(5):1804-14. PubMed ID: 25694089
[TBL] [Abstract][Full Text] [Related]
6. Delivering etoposide to the brain using catanionic solid lipid nanoparticles with surface 5-HT-moduline.
Kuo YC; Hong TY
Int J Pharm; 2014 Apr; 465(1-2):132-42. PubMed ID: 24524828
[TBL] [Abstract][Full Text] [Related]
7. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Chen YC
Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
[TBL] [Abstract][Full Text] [Related]
8. Solid lipid nanoparticles carrying chemotherapeutic drug across the blood-brain barrier through insulin receptor-mediated pathway.
Kuo YC; Shih-Huang CY
J Drug Target; 2013 Sep; 21(8):730-8. PubMed ID: 23815407
[TBL] [Abstract][Full Text] [Related]
9. Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles.
Kuo YC; Ko HF
Biomaterials; 2013 Jul; 34(20):4818-30. PubMed ID: 23545288
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme.
Wang L; Wang X; Shen L; Alrobaian M; Panda SK; Almasmoum HA; Ghaith MM; Almaimani RA; Ibrahim IAA; Singh T; Baothman AA; Choudhry H; Beg S
Biomed Pharmacother; 2021 Jun; 138():111461. PubMed ID: 33706131
[TBL] [Abstract][Full Text] [Related]
11. Solid lipid nanoparticles surface modified with anti-Contactin-2 or anti-Neurofascin for brain-targeted delivery of medicines.
Gandomi N; Varshochian R; Atyabi F; Ghahremani MH; Sharifzadeh M; Amini M; Dinarvand R
Pharm Dev Technol; 2017 May; 22(3):426-435. PubMed ID: 27575893
[TBL] [Abstract][Full Text] [Related]
12. Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment.
Chirio D; Gallarate M; Peira E; Battaglia L; Muntoni E; Riganti C; Biasibetti E; Capucchio MT; Valazza A; Panciani P; Lanotte M; Annovazzi L; Caldera V; Mellai M; Filice G; Corona S; Schiffer D
Eur J Pharm Biopharm; 2014 Nov; 88(3):746-58. PubMed ID: 25445304
[TBL] [Abstract][Full Text] [Related]
13. PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study.
Arduino I; Depalo N; Re F; Dal Magro R; Panniello A; Margiotta N; Fanizza E; Lopalco A; Laquintana V; Cutrignelli A; Lopedota AA; Franco M; Denora N
Int J Pharm; 2020 Jun; 583():119351. PubMed ID: 32339634
[TBL] [Abstract][Full Text] [Related]
14. Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies.
Battaglia L; Gallarate M; Peira E; Chirio D; Muntoni E; Biasibetti E; Capucchio MT; Valazza A; Panciani PP; Lanotte M; Schiffer D; Annovazzi L; Caldera V; Mellai M; Riganti C
J Pharm Sci; 2014 Jul; 103(7):2157-2165. PubMed ID: 24824141
[TBL] [Abstract][Full Text] [Related]
15. Effect of intracarotid infusion of etoposide: modification of the permeability of the blood-brain barrier and the blood-tumor barrier in rat brain tumor model.
Maeda Y; Matsumoto K; Mizumatsu S; Tamiya T; Furuta T; Ohmoto T
Acta Med Okayama; 1999 Feb; 53(1):5-11. PubMed ID: 10096732
[TBL] [Abstract][Full Text] [Related]
16. Cationic solid lipid nanoparticles with cholesterol-mediated surface layer for transporting saquinavir to the brain.
Kuo YC; Wang CC
Biotechnol Prog; 2014; 30(1):198-206. PubMed ID: 24167123
[TBL] [Abstract][Full Text] [Related]
17. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles.
Kuo YC; Su FL
Int J Pharm; 2007 Aug; 340(1-2):143-52. PubMed ID: 17418986
[TBL] [Abstract][Full Text] [Related]
18. Anti-glioma activity and the mechanism of cellular uptake of asiatic acid-loaded solid lipid nanoparticles.
Garanti T; Stasik A; Burrow AJ; Alhnan MA; Wan KW
Int J Pharm; 2016 Mar; 500(1-2):305-15. PubMed ID: 26775062
[TBL] [Abstract][Full Text] [Related]
19. 'Dendrimer-Cationized-Albumin' encrusted polymeric nanoparticle improves BBB penetration and anticancer activity of doxorubicin.
Muniswamy VJ; Raval N; Gondaliya P; Tambe V; Kalia K; Tekade RK
Int J Pharm; 2019 Jan; 555():77-99. PubMed ID: 30448308
[TBL] [Abstract][Full Text] [Related]
20. Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency.
Callewaert M; Dukic S; Van Gulick L; Vittier M; Gafa V; Andry MC; Molinari M; Roullin VG
J Biomed Mater Res A; 2013 May; 101(5):1319-27. PubMed ID: 23065812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
